Archon Minerals (ACS) 1.50 0.00

ARCHON MINERALS LTD
(ACS) 1.50 0.00

Last Trade:	1.41	Day Range:	1.41 - 1.41
Trade Time:	04:02PM	52wk Range:	1.38 - 1.99
Prev. Close:	1.41	Market Cap:	75.74M
Open:	0.00	Div Yield:	0
Volume:	0	PE:
EPS:	-0.03

The Latest On ACS

UPDATE: Collins Stewart Initiates Coverage on Anthera Pharmaceuticals 12/2/11 9:35am

Deutsche Bank Maintains Buy Rating and $14 PT on Anthera Pharmaceuticals 11/29/11 8:35am

Deutsche Bank Initiating Coverage on Anthera Pharmaceuticals 11/1/11 7:28am

Paul A. Rahe: Lazar Greenfield Takes the Fall 4/18/11 9:32am

Citi Maintains Buy Rating On MDRX 4/7/11 6:42am

ACS, A Xerox Company, to Acquire CredenceHealth, Inc. 3/21/11 7:02am

AstraZeneca Responds to FDA Letter - Analyst Blog 1/24/11 4:01pm

AstraZeneca Responds to FDA Letter - Analyst Blog 1/24/11 3:40pm

Volcano's IVUS More Efficient - Analyst Blog 1/20/11 1:01pm

Volcano's IVUS More Efficient - Analyst Blog 1/20/11 12:15pm

Jefferies Cuts Price Target On Merck (MRK) 1/14/11 7:19am

Anthera Resumes Trial Testing On Lupus Patients While Starting On Other New Trials 1/11/11 9:06am

UPDATE: Collins Stewart Initiates Coverage on Anthera Pharmaceuticals 12/2/11

Deutsche Bank Maintains Buy Rating and $14 PT on Anthera Pharmaceuticals 11/29/11

Deutsche Bank Initiating Coverage on Anthera Pharmaceuticals 11/1/11

Paul A. Rahe: Lazar Greenfield Takes the Fall 4/18/11

Citi Maintains Buy Rating On MDRX 4/7/11

ACS, A Xerox Company, to Acquire CredenceHealth, Inc. 3/21/11

AstraZeneca Responds to FDA Letter - Analyst Blog 1/24/11

Volcano's IVUS More Efficient - Analyst Blog 1/20/11

Jefferies Cuts Price Target On Merck (MRK) 1/14/11

Anthera Resumes Trial Testing On Lupus Patients While Starting On Other New Trials 1/11/11

Affiliated Computer Services (ACS) is ripe for correction 9/28/09

Xerox Corp. (XRX) on shaky ground after making new acqusition 9/28/09

UPDATE: Collins Stewart Initiates Coverage on Anthera Pharmaceuticals 12/2/11

Deutsche Bank Maintains Buy Rating and $14 PT on Anthera Pharmaceuticals 11/29/11

Deutsche Bank Initiating Coverage on Anthera Pharmaceuticals 11/1/11

Citi Maintains Buy Rating On MDRX 4/7/11

Jefferies Cuts Price Target On Merck (MRK) 1/14/11

Anthera Resumes Trial Testing On Lupus Patients While Starting On Other New Trials 1/11/11

Xerox S&P's Top Pick For The Week (XRX) 12/13/10

Trade ACS
NOW!

Partner Headlines

Press Releases

San Antonio Pets Alive! Receives $300,000 Grant from National Animal Welfare Organization Best Friends Animal Society 2/9/12 PRWeb Story

New Release of NCCN Guidelines for Patients: Colon Cancer; Updated NCCN Guidelines for Patients: Prostate Cancer 2/9/12 Business Wire Story

Appcelerator Acquires Cocoafish to Add Instant Mobile Cloud Capabilities to its Industry Leading Titanium Platform 2/9/12 PRWeb Story

Sensable Customers Showcase Touch-Enabled Surgical, Medical Simulation and Robotics Innovations at MMVR Conference 2/8/12 Business Wire Story

Ancillary Care Solutions to Address Incentive Compensation Plans for Physical and Occupational Therapists 2/7/12 Business Wire Story

Shawn Bethea Joins Catapult Technology as Vice President, Technology & Management Solutions 2/1/12 PRWeb Story

DriveItNow Mobile Converts On-The-Go Payment Shoppers 2/1/12 Business Wire Story

Aetna Reports Fourth-Quarter and Full-Year 2011 Results 2/1/12 Business Wire Story

Breast Surgery Specialist Dr. Janet P. Woodyard Awarded "Top Doctor" by Baltimore Magazine 1/31/12 PRWeb Story

Actuate Reports Fourth Quarter and Fiscal Year 2011 Financial Results 1/30/12 Business Wire Story

Research and Markets: Acute Coronary Syndrome (ACS) Therapeutics - Pipeline Assessment and Market Forecasts to 2018 1/30/12 Business Wire Story

New Keithley Semiconductor Software Expands Support for Reliability/High Power Device Test 1/25/12 Business Wire Story

Get the latest ACS stock news on the web. Get the latest stock quotes and much more - Benzinga is the source for ARCHON MINERALS LTD stock price.

ARCHON MINERALS LTD by YCharts

Archon Minerals (ACS) 1.50 0.00

Quotes

Analysis

Twitter

Ownership

Earnings

The Latest On ACS

From Benzinga's Newsdesk

Benzinga's News Delivered Free

Latest from Premium

Brain Trust

Popular Channels

Tools & Features

About Benzinga

Social